|
1
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide, IARC CancerBase No. 11. International Agency for
Research on Cancer Lyon (France). 2013 http://globocan.iarc.frAccessed. September
15–2015.
|
|
3
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ono H, Kondo H, Gotoda T, Shirao K,
Yamaguchi H, Saito D, Hosokawa K, Shimoda T and Yoshida S:
Endoscopic mucosal resection for treatment of early gastric cancer.
Gut. 48:225–229. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gotoda T, Yamamoto H and Soetikno RM:
Endoscopic submucosal dissection of early gastric cancer. J
Gastroenterol. 41:929–942. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
An international association between
Helicobacter-pylori infection and gastric-cancer. The
EUROGAST Study Group. Lancet. 341:1359–1362. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dias-Neto M, Pintalhao M, Ferreira M and
Lunet N: Salt intake and risk of gastric intestinal metaplasia:
Systematic review and meta-analysis. Nutr Cancer. 62:133–147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsugane S: Salt, salted food intake, and
risk of gastric cancer: Epidemiologic evidence. Cancer Sci. 96:1–6.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
International Human Genome Sequencing
Consortium: Finishing the euchromatic sequence of the human genome.
Nature. 431:931–945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gaudet F, Hodgson JG, Eden A,
Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R:
Induction of tumors in mice by genomic hypomethylation. Science.
300:489–492. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Merlo A, Herman JG, Mao L, Lee DJ,
Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island
methylation is associated with transcriptional silencing of the
tumor-suppressor p16/CDKN2/MTS1 in human cancers. Nat Med.
1:686–692. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Graziano F, Arduini F, Ruzzo A, Bearzi I,
Humar B, More H, Silva R, Muretto P, Guilford P, Testa E, et al:
Prognostic analysis of E-cadherin gene promoter hypermethylation in
patients with surgically resected, node-positive, diffuse gastric
cancer. Clin Cancer Res. 10:2784–2789. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Maat MF, van de Velde CJ, Umetani N, de
Heer P, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen
PJ, Bilchik AJ, et al: Epigenetic silencing of cyclooxygenase-2
affects clinical outcome in gastric cancer. J Clin Oncol.
25:4887–4894. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ooki A, Yamashita K, Kikuchi S, Sakuramoto
S, Katada N, Kokubo K, Kobayashi H, Kim MS, Sidransky D and
Watanabe M: Potential utility of HOP homeobox gene promoter
methylation as a marker of tumor aggressiveness in gastric cancer.
Oncogene. 29:3263–3275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q,
Jin H, Zeng Z, Sung JJ and Yu J: Epigenetic inactivation of BCL6B,
a novel functional tumour suppressor for gastric cancer, is
associated with poor survival. Gut. 61:977–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Cheung KF, Ma X, Tian L, Zhao J, Go
MY, Shen B, Cheng AS, Ying J, Tao Q, et al: Epigenetic inactivation
of paired box gene 5, a novel tumor suppressor gene, through direct
upregulation of p53 is associated with prognosis in gastric cancer
patients. Oncogene. 31:3419–3430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du W, Wang S, Zhou Q, Li X, Chu J, Chang
Z, Tao Q, Ng EK, Fang J, Sung JJ and Yu J: ADAMTS9 is a functional
tumor suppressor through inhibiting AKT/mTOR pathway and associated
with poor survival in gastric cancer. Oncogene. 32:3319–3328. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang
H, Kang W, Li X, Tao Q, Sung JJ and Yu J: Zinc-finger protein 545
is a novel tumour suppressor that acts by inhibiting ribosomal RNA
transcription in gastric cancer. Gut. 62:833–841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo W, Dong Z, Guo Y, Lin X, Chen Z, Kuang
G and Yang Z: Aberrant methylation and loss expression of RKIP is
associated with tumor progression and poor prognosis in gastric
cardia adenocarcinoma. Clin Exp Metastasis. 30:265–275. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cravo M, Pinto R, Fidalgo P, Chaves P,
Glória L, Nobre-Leitão C and Costa Mira F: Global DNA
hypomethylation occurs in the early stages of intestinal type
gastric carcinoma. Gut. 39:434–438. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Balassiano K, Lima S, Jenab M, Overvad K,
Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F,
Kaaks R, Boeing H, et al: Aberrant DNA methylation of
cancer-associated genes in gastric cancer in the European
Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Cancer Lett. 311:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bae JM, Shin SH, Kwon HJ, Park SY, Kook
MC, Kim YW, Cho NY, Kim N, Kim TY, Kim D and Kang GH: ALU and
LINE-1 hypomethylations in multistep gastric carcinogenesis and
their prognostic implications. Int J Cancer. 131:1323–1331. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shigaki H, Baba Y, Watanabe M, Murata A,
Iwagami S, Miyake K, Ishimoto T, Iwatsuki M and Baba H: LINE-1
hypomethylation in gastric cancer, detected by bisulfite
pyrosequencing, is associated with poor prognosis. Gastric Cancer.
16:480–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maekita T, Nakazawa K, Mihara M, Nakajima
T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M,
et al: High levels of aberrant DNA methylation in Helicobacter
pylori-infected gastric mucosae and its possible association
with gastric cancer risk. Clin Cancer Res. 12:989–995. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan AO, Lam SK, Wong BC, Wong WM, Yuen
MF, Yeung YH, Hui WM, Rashid A and Kwong YL: Promoter methylation
of E-cadherin gene in gastric mucosa associated with
Helicobacter pylori infection and in gastric cancer. Gut.
52:502–506. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang GH, Lee S, Kim WH, Lee HW, Kim JC,
Rhyu MG and Ro JY: Epstein-barr virus-positive gastric carcinoma
demonstrates frequent aberrant methylation of multiple genes and
constitutes CpG island methylator phenotype-positive gastric
carcinoma. Am J Pathol. 160:787–794. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu D, Qu L, Hu J, Li G, Lv P, Ma D, Guo M
and Chen Y: Transmembrane protein 106A is silenced by promoter
region hypermethylation and suppresses gastric cancer growth by
inducing apoptosis. J Cell Mol Med. 18:1655–1666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim HG, Lee S, Kim DY, Ryu SY, Joo JK, Kim
JC, Lee KH and Lee JH: Aberrant methylation of DNA mismatch repair
genes in elderly patients with sporadic gastric carcinoma: A
comparison with younger patients. J Surg Oncol. 101:28–35. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luco RF, Pan Q, Tominaga K, Blencowe BJ,
Pereira-Smith OM and Misteli T: Regulation of alternative splicing
by histone modifications. Science. 327:996–1000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishiyama A, Yamaguchi L, Sharif J,
Johmura Y, Kawamura T, Nakanishi K, Shimamura S, Arita K, Kodama T,
Ishikawa F, et al: Uhrf1-dependent H3K23 ubiquitylation couples
maintenance DNA methylation and replication. Nature. 502:249–253.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barski A, Cuddapah S, Cui K, Roh TY,
Schones DE, Wang Z, Wei G, Chepelev I and Zhao K: High-resolution
profiling of histone methylations in the human genome. Cell.
129:823–837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Archer SY and Hodin RA: Histone
acetylation and cancer. Curr Opin Genet Dev. 9:171–174. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ota T, Suto S, Katayama H, Han ZB, Suzuki
F, Maeda M, Tanino M, Terada Y and Tatsuka M: Increased mitotic
phosphorylation of histone H3 attributable to AIM-1/Aurora-B
overexpression contributes to chromosome number instability. Cancer
Res. 62:5168–5177. 2002.PubMed/NCBI
|
|
35
|
Ke Q, Davidson T, Chen H, Kluz T and Costa
M: Alterations of histone modifications and transgene silencing by
nickel chloride. Carcinogenesis. 27:1481–1488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cai L, Ma X, Huang Y, Zou Y and Chen X:
Aberrant histone methylation and the effect of Suv39H1 siRNA on
gastric carcinoma. Oncol Rep. 31:2593–2600. 2014.PubMed/NCBI
|
|
38
|
Yekta S, Shih IH and Bartel DP:
MicroRNA-directed cleavage of HOXB8 mRNA. Science. 304:594–596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hutvagner G and Zamore PD: A microRNA in a
multiple-turnover RNAi enzyme complex. Science. 297:2056–2060.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu K, Qian T, Tang L, Wang J, Yang H and
Ren J: Decreased expression of microRNA let-7i and its association
with chemotherapeutic response in human gastric cancer. World J
Surg Oncol. 10:2252012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Inoue T, Iinuma H, Ogawa E, Inaba T and
Fukushima R: Clinicopathological and prognostic significance of
microRNA-107 and its relationship to DICER1 mRNA expression in
gastric cancer. Oncol Rep. 27:1759–1764. 2012.PubMed/NCBI
|
|
43
|
Wang YY, Ye ZY, Zhao ZS, Li L, Wang YX,
Tao HQ, Wang HJ and He XJ: Clinicopathologic significance of
miR-10b expression in gastric carcinoma. Hum Pathol. 44:1278–1285.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hashiguchi Y, Nishida N, Mimori K, Sudo T,
Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y and Mori
M: Down-regulation of miR-125a-3p in human gastric cancer and its
clinicopathological significance. Int J Oncol. 40:1477–1482.
2012.PubMed/NCBI
|
|
45
|
Guo LH, Li H, Wang F, Yu J and He JS: The
tumor suppressor roles of miR-433 and miR-127 in gastric cancer.
Int J Mol Sci. 14:14171–14184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu X, Yu H, Cai H and Wang Y: The
expression and clinical significance of miR-132 in gastric cancer
patients. Diagn Pathol. 9:572014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC,
Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, et al: MicroRNA 135a
suppresses lymph node metastasis through down-regulation of ROCK1
in early gastric cancer. PLoS One. 9:e852052014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo
ZY, Zhao J, Meng YL, Ren XL, Wang T, et al: HER2 interacts with
CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139
in gastric cancer cells. Gastroenterology. 141:2076–2087.e6. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Naito Y, Sakamoto N, Oue N, Yashiro M,
Sentani K, Yanagihara K, Hirakawa K and Yasui W: MicroRNA-143
regulates collagen type III expression in stromal fibroblasts of
scirrhous type gastric cancer. Cancer Sci. 105:228–235. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Akiyoshi S, Fukagawa T, Ueo H, Ishibashi
M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K and Mori M:
Clinical significance of miR-144-ZFX axis in disseminated tumour
cells in bone marrow in gastric cancer cases. Br J Cancer.
107:1345–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sakamoto N, Naito Y, Oue N, Sentani K,
Uraoka N, Zarni Oo H, Yanagihara K, Aoyagi K, Sasaki H and Yasui W:
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and
indicates tumor invasiveness and poor prognosis. Cancer Sci.
105:236–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
54
|
Chen G, Shen ZL, Wang L, Lv CY, Huang XE
and Zhou RP: Hsa-miR-181a-5p expression and effects on cell
proliferation in gastric cancer. Asian Pac J Cancer Prev.
14:3871–3875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tan Z, Jiang H, Wu Y, Xie L, Dai W, Tang H
and Tang S: miR-185 is an independent prognosis factor and
suppresses tumor metastasis in gastric cancer. Mol Cell Biochem.
386:223–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Brenner B, Hoshen MB, Purim O, David MB,
Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern
M, et al: MicroRNAs as a potential prognostic factor in gastric
cancer. World J Gastroenterol. 17:3976–3985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L,
Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
Novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang W, Li F, Zhang Y, Tu Y, Yang Q and
Gao X: Reduced expression of miR-22 in gastric cancer is related to
clinicopathologic characteristics or patient prognosis. Diagn
Pathol. 8:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu K, Li G, Fan C, Diao Y, Wu B and Li J:
Increased expression of MicroRNA-221 in gastric cancer and its
clinical significance. J Int Med Res. 40:467–474. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu
Y, Gu Q, Zhu Z and Liu B: Overexpressed miR-301a promotes cell
proliferation and invasion by targeting RUNX3 in gastric cancer. J
Gastroenterol. 48:1023–1033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang
Z, Chen F and Zheng G: Identification hsa-miR-335 as a prognostic
signature in gastric cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zheng B, Liang L, Huang S, Zha R, Liu L,
Jia D, Tian Q, Wang Q, Wang C, Long Z, et al: MicroRNA-409
suppresses tumour cell invasion and metastasis by directly
targeting radixin in gastric cancers. Oncogene. 31:4509–4516. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Osawa S, Shimada Y, Sekine S, Okumura T,
Nagata T, Fukuoka J and Tsukada K: MicroRNA profiling of gastric
cancer patients from formalin-fixed paraffin-embedded samples.
Oncol Lett. 2:613–619. 2011.PubMed/NCBI
|
|
66
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: microRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Iwaya T, Fukagawa T, Suzuki Y, Takahashi
Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K,
et al: Contrasting expression patterns of histone mRNA and microRNA
760 in patients with gastric cancer. Clin Cancer Res. 19:6438–6449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
He W, Li Y, Chen X, Lu L, Tang B, Wang Z,
Pan Y, Cai S, He Y and Ke Z: miR-494 acts as an anti-oncogene in
gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol.
29:1427–1434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Stenholm L, Stoehlmacher-Williams J,
Al-Batran SE, Heussen N, Akin S, Pauligk C, Lehmann S, Senff T,
Hofheinz RD, Ehninger G, et al: Prognostic role of microRNA
polymorphisms in advanced gastric cancer: A translational study of
the Arbeitsgemeinschaft Internistische Onkologie (AIO). Ann Oncol.
24:2581–2588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang
W, Ma Y and Xiao H: Genome-wide microRNA profiles identify miR-378
as a serum biomarker for early detection of gastric cancer. Cancer
Lett. 316:196–203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Gutschner T, Hammerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses
epithelial-mesenchymal transition in gastric cancer. Int J Biol
Sci. 9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi
K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric
carcinoma cell proliferation by increasing c-Myc mRNA stability.
FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lee KS, Park JL, Lee K, Richardson LE,
Johnson BH, Lee HS, Lee JS, Kim SB, Kwon OH, Song KS, et al: nc886,
a non-coding RNA of anti-proliferative role, is suppressed by CpG
DNA methylation in human gastric cancer. Oncotarget. 5:3944–3955.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, et al: Decreased expression of
the long non-coding RNA FENDRR is associated with poor prognosis in
gastric cancer and FENDRR regulates gastric cancer cell metastasis
by affecting fibronectin1 expression. J Hematol Oncol. 7:632014.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Han Y, Ye J, Wu D, Wu P, Chen Z, Chen J,
Gao S and Huang J: LEIGC long non-coding RNA acts as a tumor
suppressor in gastric carcinoma by inhibiting the
epithelial-to-mesenchymal transition. BMC Cancer. 14:9322014.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Xu MD, Qi P, Weng WW, Shen XH, Ni SJ, Dong
L, Huang D, Tan C, Sheng WQ, Zhou XY and Du X: Long non-coding RNA
LSINCT5 predicts negative prognosis and exhibits oncogenic activity
in gastric cancer. Medicine (Baltimore). 93:e3032014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
